Verinos Pharma
Pre-clinicalDevelops novel immunotherapies for cancer treatment using targeted protein degradation platforms.
Founded
2021
Focus
Small Molecules
About
Develops novel immunotherapies for cancer treatment using targeted protein degradation platforms.
Funding History
2Total raised: $17.5M
Series A$15MAndera PartnersMar 15, 2023
Seed$2.5MHigh-Tech GründerfondsJun 15, 2021
Company Info
TypePrivate
Founded2021
LocationMunich, Germany
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile